Journal of Food Science,
Journal Year:
2023,
Volume and Issue:
88(9), P. 3967 - 3983
Published: Aug. 7, 2023
Accumulating
evidence
suggests
that
specific
probiotic
strains
exert
hypoglycemic
effects
on
type
2
diabetes
mellitus
(T2DM),
and
within
Bifidobacterium
exhibit
potential
beneficial
T2DM.
In
this
study,
α-glucosidase
inhibitory
activities
of
14
were
assessed
in
vitro.
The
longum
WHH2270
with
high
activity
(42.03%)
then
investigated
a
high-fat
diet/streptozotocin-induced
T2DM
rat
model.
Oral
administration
(4
×
109
CFU/kg/day)
for
8
weeks
significantly
reversed
the
reduced
body
weight
ameliorated
levels
fasting
blood
glucose,
serum
triglyceride,
total
cholesterol,
glucose
tolerance,
insulin
resistance
rats.
Using
16S
rRNA
high-throughput
sequencing
feces,
was
revealed
to
reshape
gut
microbiome
composition
by
increasing
abundances
Lactobacillus
decreasing
UCG_005,
Clostridium,
Faecalibacterium
Besides,
fecal
short-chain
fatty
acids
(SCFAs)
including
acetate,
propionate,
butyrate
also
elevated
after
administration.
Moreover,
gene
expressions
SCFA
receptors
FFAR2
FFAR3
colon
pancreas
rats
restored
administration,
accompanied
increased
acetate.
summary,
these
results
provide
has
improve
symptoms
alleviating
hyperglycemia,
which
associated
changes
production.
PRACTICAL
APPLICATION:
may
serve
as
promising
agent
treatment
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(15), P. 8493 - 8493
Published: July 31, 2022
Depression
is
a
common
and
serious
disorder,
characterized
by
symptoms
like
anhedonia,
lack
of
energy,
sad
mood,
low
appetite,
sleep
disturbances.
This
disease
very
complex
not
totally
elucidated,
in
which
diverse
molecular
biological
mechanisms
are
involved,
such
as
neuroinflammation.
There
high
need
for
the
development
new
therapies
gaining
insights
into
this
urgent.
One
important
player
depression
amino
acid
tryptophan.
can
be
metabolized
two
pathways
context
depression:
serotonin
kynurenine
pathways.
These
metabolic
tryptophan
crucial
several
processes
that
linked
with
depression.
Indeed,
maintenance
balance
critical
human
physiological
homeostasis.
Thus,
narrative
review
aims
to
explore
metabolism
(particularly
pathways)
depression,
starting
global
overview
about
these
topics
ending
focus
on
neuroinflammation,
stress,
microbiota,
brain-derived
neurotrophic
factor
regulation
disease.
Taken
together,
information
clarify
particularly
Trends in Food Science & Technology,
Journal Year:
2023,
Volume and Issue:
138, P. 178 - 198
Published: June 11, 2023
The
human
gut
hosts
complex
microbial
communities,
which
are
linked
to
health
and
disease.
microbiota
is
continuously
reshaped
by
multiple
environmental
factors,
especially
diet.
Gut
dysbiosis
may
promote
various
metabolic,
neurological,
intestinal,
cardiovascular
diseases,
even
tumor
development.
Probiotics
have
shown
promising
prophylactic,
mitigating,
or
curative
effects
when
use
as
nutrient
supplements
adjunctive
therapy.
These
beneficial
and/or
symptom
alleviation
often
accompanied
microbiome
metabolome
changes.
Differing
from
other
published
review
articles,
here
we
summarized
the
latest
knowledge
of
evidence-based
health-promoting
probiotics
scouring
literature
recent
animal
probiotic
intervention
studies.
To
elucidate
mechanisms
in
enhancing
intestinal
homeostasis,
barrier
function,
host
immunity,
through
modulating
its
metabolites.
Meanwhile,
also
discussed
challenges
data
analysis
clinical
research
comparison
between
laboratories,
provides
an
outlook
for
future
perspectives
applications
probiotics.
achieved
modulation.
Current
discussed.
Finally,
provided.
The Journal of Physiology,
Journal Year:
2023,
Volume and Issue:
601(20), P. 4491 - 4538
Published: Sept. 27, 2023
The
physiological
consequences
of
stress
often
manifest
in
the
gastrointestinal
tract.
Traumatic
or
chronic
is
associated
with
widespread
maladaptive
changes
throughout
gut,
although
comparatively
little
known
about
effects
acute
stress.
Furthermore,
these
stress-induced
gut
may
increase
susceptibility
to
disorders
and
infection,
impact
critical
features
neural
behavioural
response
by
impairing
gut-brain
axis
communication.
Understanding
mechanisms
behind
enteric
nervous
system
circuitry,
visceral
sensitivity,
barrier
function,
permeability,
microbiota
following
an
important
research
objective
pathophysiological
implications
both
neurogastroenterology
psychiatry.
Moreover,
has
emerged
as
a
key
aspect
physiology
sensitive
In
this
review,
we
focus
on
different
aspects
tract
including
function
well
immune,
humoral
neuronal
elements
involved
discuss
evidence
for
role
disorders.
Existing
gaps
current
literature
are
highlighted,
possible
avenues
future
integrated
perspective
have
been
suggested.
A
more
complete
understanding
spatial
temporal
dynamics
host
microbial
kinds
stressors
will
enable
full
exploitation
diagnostic
therapeutic
potential
fast-evolving
field
host-microbiome
interactions.
Medicine,
Journal Year:
2024,
Volume and Issue:
103(5), P. e37114 - e37114
Published: Feb. 2, 2024
The
gastrointestinal
tract
is
embedded
with
microorganisms
of
numerous
genera,
referred
to
as
gut
microbiota.
Gut
microbiota
has
multiple
effects
on
many
body
organs,
including
the
brain.
There
a
bidirectional
connection
between
and
brain
called
gut-brain-axis,
these
connections
are
formed
through
immunological,
neuronal,
neuroendocrine
pathways.
In
addition,
modulates
synthesis
functioning
neurotransmitters.
Therefore,
disruption
in
composition
or
function,
which
known
dysbiosis,
associated
pathogenesis
mental
disorders,
such
schizophrenia,
depression,
other
psychiatric
disorders.
This
review
aims
summarize
modulation
role
4
prominent
neurotransmitters
(tryptophan
serotonergic
system,
dopamine,
gamma-aminobutyric
acid,
glutamate),
well
its
association
disorders
(schizophrenia,
anxiety
autism
spectrum
disorder).
More
future
research
required
develop
efficient
gut-microbiota-based
therapies
for
illnesses.
Antioxidants,
Journal Year:
2024,
Volume and Issue:
13(4), P. 484 - 484
Published: April 18, 2024
The
antioxidant
and
anti-inflammatory
effects
of
hormetic
nutrition
for
enhancing
stress
resilience
overall
human
health
have
received
much
attention.
Recently,
the
gut-brain
axis
has
attracted
prominent
interest
preventing
therapeutically
impacting
neuropathologies
gastrointestinal
diseases.
Polyphenols
polyphenol-combined
nanoparticles
in
synergy
with
probiotics
shown
to
improve
gut
bioavailability
blood-brain
barrier
(BBB)
permeability,
thus
inhibiting
oxidative
stress,
metabolic
dysfunction
inflammation
linked
dysbiosis
ultimately
onset
progression
central
nervous
system
(CNS)
disorders.
In
accordance
hormesis,
polyphenols
display
biphasic
dose-response
by
activating
at
a
low
dose
Nrf2
pathway
resulting
upregulation
International Journal of Molecular Sciences,
Journal Year:
2025,
Volume and Issue:
26(2), P. 614 - 614
Published: Jan. 13, 2025
The
complex
relationship
between
diet,
the
gut
microbiota,
and
mental
health,
particularly
depression,
has
become
a
focal
point
of
contemporary
research.
This
critical
review
examines
how
specific
dietary
components,
such
as
fiber,
proteins,
fats,
vitamins,
minerals,
bioactive
compounds,
shape
microbiome
influence
microbial
metabolism
in
order
to
regulate
depressive
outcomes.
These
dietary-induced
changes
microbiota
can
modulate
production
metabolites,
which
play
vital
roles
gut–brain
communication.
axis
facilitates
this
communication
through
neural,
immune,
endocrine
pathways.
Alterations
metabolites
central
nervous
system
(CNS)
functions
by
impacting
neuroplasticity,
inflammatory
responses,
neurotransmitter
levels—all
are
linked
onset
course
depression.
highlights
recent
findings
linking
components
with
beneficial
composition
reduced
symptoms.
We
also
explore
challenges
individual
variability
responses
interventions
long-term
sustainability
these
strategies.
underscores
necessity
for
further
longitudinal
mechanistic
studies
elucidate
precise
mechanisms
diet
interactions
be
leveraged
mitigate
paving
way
personalized
nutritional
therapies.
Frontiers in Neurology,
Journal Year:
2022,
Volume and Issue:
13
Published: Nov. 10, 2022
Depression
is
a
worldwide
disease
causing
severe
disability,
morbidity,
and
mortality.
Despite
abundant
studies,
the
precise
mechanisms
underlying
pathophysiology
of
depression
remain
elusive.
Recently,
cumulate
research
suggests
that
disturbance
microbiota-gut-brain
axis
may
play
vital
role
in
etiology
while
correcting
this
could
alleviate
symptoms.
The
vagus
nerve,
linking
brain
gut
through
its
afferent
efferent
branches,
critical
route
bidirectional
communication
axis.
Directly
or
indirectly,
fibers
can
sense
relay
microbiota
signals
to
induce
disorders
including
depression.
Also,
changes
response
stress
result
hyperpermeability
inflammation
mediating
by
vagal
efferents,
which
be
detrimental
Notably,
nerve
stimulation
owns
an
anti-inflammatory
effect
was
proved
for
treatment.
Nevertheless,
accompanied
low
tone,
derive
from
contribute
pathogenesis
In
review,
we
aim
explore
perspective
axis,
highlighting
relationship
among
hyperpermeability,
inflammation,
Pharmacological Research,
Journal Year:
2023,
Volume and Issue:
192, P. 106799 - 106799
Published: May 19, 2023
Depression
is
the
most
prevalent
mental
disorder
in
world
associated
with
huge
socio-economic
consequences.
While
depressive-related
symptoms
are
well
known,
molecular
mechanisms
underlying
disease
pathophysiology
and
progression
remain
largely
unknown.
The
gut
microbiota
(GM)
emerging
as
a
key
regulator
of
central
nervous
system
homeostasis
by
exerting
fundamental
immune
metabolic
functions.
In
turn,
brain
influences
intestinal
microbial
composition
through
neuroendocrine
signals,
within
so-called
microbiota-brain
axis.
balance
this
bidirectional
crosstalk
important
to
ensure
neurogenesis,
preserve
integrity
blood-brain
barrier
avoid
neuroinflammation.
Conversely,
dysbiosis
permeability
negatively
affect
development,
behavior,
cognition.
Furthermore,
although
not
fully
defined
yet,
changes
GM
depressed
patients
reported
influence
pharmacokinetics
common
antidepressants
affecting
their
absorption,
metabolism,
activity.
Similarly,
neuropsychiatric
drugs
may
shape
turn
an
impact
on
efficacy
toxicity
pharmacological
intervention
itself.
Consequently,
strategies
aimed
at
re-establishing
correct
homeostatic
(i.e.,
prebiotics,
probiotics,
fecal
transplantation,
dietary
interventions)
represent
innovative
approach
improve
pharmacotherapy
depression.
Among
these,
probiotics
Mediterranean
diet,
alone
or
combination
standard
care,
hold
promise
for
clinical
application.
Therefore,
disclosure
intricate
network
between
depression
will
give
precious
insights
diagnostic
therapeutic
approaches
towards
depression,
profound
implications
drug
development
practice.
ASN NEURO,
Journal Year:
2023,
Volume and Issue:
15
Published: Jan. 1, 2023
Depression
increasingly
affects
a
wide
range
and
large
number
of
people
worldwide,
both
physically
psychologically,
which
makes
it
social
problem
requiring
prompt
attention
management.
Accumulating
clinical
animal
studies
have
provided
us
with
substantial
insights
disease
pathogenesis,
especially
central
monoamine
deficiency,
considerably
promotes
antidepressant
research
treatment.
The
first-line
antidepressants
mainly
target
the
system,
whose
drawbacks
include
slow
action
treatment
resistant.
novel
esketamine,
targeting
on
glutamatergic
rapidly
robustly
alleviates
depression
(including
treatment-resistant
depression),
efficiency
is
shadowed
by
potential
addictive
psychotomimetic
side
effects.
Thus,
exploring
pathogenesis
necessary,
for
seeking
more
safe
effective
therapeutic
methods.
Emerging
evidence
has
revealed
vital
involvement
oxidative
stress
(OS)
in
depression,
inspires
to
pursue
antioxidant
pathway
prevention
Fully
uncovering
underlying
mechanisms
OS-induced
first
step
towards
avenue,
thus
we
summarize
expound
possible
downstream
pathways
OS,
including
mitochondrial
impairment
related
ATP
neuroinflammation,
glutamate
excitotoxicity,
brain-derived
neurotrophic
factor/tyrosine
receptor
kinase
B
dysfunction
serotonin
microbiota-gut-brain
axis
disturbance
hypothalamic-pituitary-adrenocortical
dysregulation.
We
also
elaborate
intricate
interactions
between
multiple
aspects,
molecular
mediating
interplay.
Through
reviewing
progress
field,
hope
depict
an
integral
overview
how
OS
induces
order
provide
fresh
ideas
targets
final
goal
efficient
disease.
Journal of Traditional and Complementary Medicine,
Journal Year:
2024,
Volume and Issue:
14(3), P. 237 - 255
Published: March 21, 2024
This
review
aims
to
argue
how
using
probiotics
can
improve
anxiety
and
depressive
behaviour
without
adverse
effects,
also
exploring
the
impact
of
postbiotics
on
it.
Specifically,
have
drawn
more
attention
as
effective
alternative
treatments,
considering
rising
cost
antidepressant
anti-anxiety
drugs
high
risk
side
effects.
Depression
disorders
are
among
most
common
mental
illnesses
in
world's
population,
characterised
by
low
mood,
poor
general
interest,
cognitive
or
motor
dysfunction.
Thus,
this
study
analyzed
published
literature
anxiety,
depression,
probiotic
supplementation
from
PubMed
Scopus,
focusing
last
twenty
years.
focused
effect
health
they
because
their
extensive
clinical
applications
positive
various
diseases.
Numerous
studies
demonstrated
gut
microbiota
might
be
critical
for
mood
regulation
affect
host
regulating
gut-brain
axis.
By
comparing
different
works
analysed,
it
was
possible
identify
a
strategy
which
selected
employed
and,
at
same
time,
assess
optimised
postbiotics,
an
innovation
well-being
humans.